126 related articles for article (PubMed ID: 16552834)
21. Lipopolysaccharide enhances oxidative modification of low density lipoprotein by copper ions, endothelial and smooth muscle cells.
Maziere C; Conte MA; Dantin F; Maziere JC
Atherosclerosis; 1999 Mar; 143(1):75-80. PubMed ID: 10208481
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory activity of the extracts from mycelia of Antrodia camphorata cultured with water-soluble fractions from five different Cinnamomum species.
Shen YC; Chou CJ; Wang YH; Chen CF; Chou YC; Lu MK
FEMS Microbiol Lett; 2004 Feb; 231(1):137-43. PubMed ID: 14769478
[TBL] [Abstract][Full Text] [Related]
23. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.
Kontush A; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1881-8. PubMed ID: 12920049
[TBL] [Abstract][Full Text] [Related]
24. Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein.
Exner M; Hermann M; Hofbauer R; Kapiotis S; Quehenberger P; Speiser W; Held I; Gmeiner BM
Free Radic Res; 2001 Jan; 34(1):101-12. PubMed ID: 11234992
[TBL] [Abstract][Full Text] [Related]
25. Aluminum ions stimulate the oxidizability of low density lipoprotein by Fe2+: implication in hemodialysis mediated atherogenic LDL modification.
Kapiotis S; Hermann M; Exner M; Sturm BN; Scheiber-Mojdehkar B; Goldenberg H; Kopp S; Chiba P; Gmeiner BM
Free Radic Res; 2005 Nov; 39(11):1225-31. PubMed ID: 16298749
[TBL] [Abstract][Full Text] [Related]
26. Diphenyl diselenide, a simple glutathione peroxidase mimetic, inhibits human LDL oxidation in vitro.
de Bem AF; Farina M; Portella Rde L; Nogueira CW; Dinis TC; Laranjinha JA; Almeida LM; Rocha JB
Atherosclerosis; 2008 Nov; 201(1):92-100. PubMed ID: 18440006
[TBL] [Abstract][Full Text] [Related]
27. Oximes as inhibitors of low density lipoprotein oxidation.
de Lima Portella R; Barcelos RP; de Bem AF; Carratu VS; Bresolin L; da Rocha JB; Soares FA
Life Sci; 2008 Dec; 83(25-26):878-85. PubMed ID: 18992260
[TBL] [Abstract][Full Text] [Related]
28. Antrodia camphorata ATCC 200183 sporulates asexually in submerged culture.
Geng Y; He Z; Lu ZM; Xu HY; Xu GH; Shi JS; Xu ZH
Appl Microbiol Biotechnol; 2013 Apr; 97(7):2851-8. PubMed ID: 23104644
[TBL] [Abstract][Full Text] [Related]
29. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
Fuhrman B; Volkova N; Rosenblat M; Aviram M
Antioxid Redox Signal; 2000; 2(3):491-506. PubMed ID: 11229363
[TBL] [Abstract][Full Text] [Related]
30. Evidence for inhibition of low density lipoprotein oxidation and cholesterol accumulation by apolipoprotein H (beta2-glycoprotein I).
Lin KY; Pan JP; Yang DL; Huang KT; Chang MS; Ding PY; Chiang AN
Life Sci; 2001 Jun; 69(6):707-19. PubMed ID: 11476192
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of LDL oxidation by a new estradiol receptor modulator compound LY-139478, comparative effect with other steroids.
Rattan AK; Arad Y
Atherosclerosis; 1998 Feb; 136(2):305-14. PubMed ID: 9543102
[TBL] [Abstract][Full Text] [Related]
32. S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
Breugnot C; Privat S; Guillonneau C; Regnier G; Bouzom F; Vilaine JP; Lenaers A
J Pharmacol Exp Ther; 1994 May; 269(2):515-20. PubMed ID: 8182520
[TBL] [Abstract][Full Text] [Related]
33. Effects of Antrodia camphorata extracts on anti-oxidation, anti-mutagenesis and protection of DNA against hydroxyl radical damage.
Hsieh YL; Wu SP; Fang LW; Hwang TS
BMC Complement Altern Med; 2015 Jul; 15():237. PubMed ID: 26179175
[TBL] [Abstract][Full Text] [Related]
34. Anti-inflammatory potential of Antrodia Camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-kappaB pathway.
Hseu YC; Wu FY; Wu JJ; Chen JY; Chang WH; Lu FJ; Lai YC; Yang HL
Int Immunopharmacol; 2005 Dec; 5(13-14):1914-25. PubMed ID: 16275626
[TBL] [Abstract][Full Text] [Related]
35. Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1).
Matthews AJ; Vercellotti GM; Menchaca HJ; Bloch PH; Michalek VN; Marker PH; Murar J; Buchwald H
J Surg Res; 1997 Nov; 73(1):35-40. PubMed ID: 9441790
[TBL] [Abstract][Full Text] [Related]
36. Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells.
Horie S; Hiraishi S; Hirata Y; Kazama M; Matsuda J
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):277-85. PubMed ID: 11085919
[TBL] [Abstract][Full Text] [Related]
37. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor.
Jeong TS; Kim KS; Kim JR; Cho KH; Lee S; Lee WS
Bioorg Med Chem Lett; 2004 Jun; 14(11):2719-23. PubMed ID: 15125921
[TBL] [Abstract][Full Text] [Related]
38. [The effect of vitamin C in oxidative modification of low-density lipoprotein induced by macrophage and copperion].
Chen Y; Yang Q; Yang Y; Zhang X
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):25-9. PubMed ID: 11955344
[TBL] [Abstract][Full Text] [Related]
39. Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo.
Hseu YC; Chen SC; Chen HC; Liao JW; Yang HL
Food Chem Toxicol; 2008 Aug; 46(8):2680-8. PubMed ID: 18550246
[TBL] [Abstract][Full Text] [Related]
40. Acetylcholine esterase protects LDL against oxidation.
Fuhrman B; Partoush A; Aviram M
Biochem Biophys Res Commun; 2004 Sep; 322(3):974-8. PubMed ID: 15336559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
